Cargando…
Growth restriction of an experimental live attenuated human parainfluenza virus type 2 vaccine in human ciliated airway epithelium in vitro parallels attenuation in African green monkeys
Human parainfluenza viruses (HPIVs) are common causes of severe pediatric respiratory viral disease. We characterized wild-type HPIV2 infection in an in vitro model of human airway epithelium (HAE) and found that the virus replicates to high titer, sheds apically, targets ciliated cells, and induces...
Autores principales: | , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd. Published by Elsevier Ltd.
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2844349/ https://www.ncbi.nlm.nih.gov/pubmed/20139039 http://dx.doi.org/10.1016/j.vaccine.2010.01.050 |
_version_ | 1782179290996015104 |
---|---|
author | Schaap-Nutt, Anne Scull, Margaret A. Schmidt, Alexander C. Murphy, Brian R. Pickles, Raymond J. |
author_facet | Schaap-Nutt, Anne Scull, Margaret A. Schmidt, Alexander C. Murphy, Brian R. Pickles, Raymond J. |
author_sort | Schaap-Nutt, Anne |
collection | PubMed |
description | Human parainfluenza viruses (HPIVs) are common causes of severe pediatric respiratory viral disease. We characterized wild-type HPIV2 infection in an in vitro model of human airway epithelium (HAE) and found that the virus replicates to high titer, sheds apically, targets ciliated cells, and induces minimal cytopathology. Replication of an experimental, live attenuated HPIV2 vaccine strain, containing both temperature sensitive (ts) and non-ts attenuating mutations, was restricted >30-fold compared to rHPIV2-WT in HAE at 32 °C and exhibited little productive replication at 37 °C. This restriction paralleled attenuation in the upper and lower respiratory tract of African green monkeys, supporting the HAE model as an appropriate and convenient system for characterizing HPIV2 vaccine candidates. |
format | Text |
id | pubmed-2844349 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Elsevier Ltd. Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-28443492011-03-24 Growth restriction of an experimental live attenuated human parainfluenza virus type 2 vaccine in human ciliated airway epithelium in vitro parallels attenuation in African green monkeys Schaap-Nutt, Anne Scull, Margaret A. Schmidt, Alexander C. Murphy, Brian R. Pickles, Raymond J. Vaccine Article Human parainfluenza viruses (HPIVs) are common causes of severe pediatric respiratory viral disease. We characterized wild-type HPIV2 infection in an in vitro model of human airway epithelium (HAE) and found that the virus replicates to high titer, sheds apically, targets ciliated cells, and induces minimal cytopathology. Replication of an experimental, live attenuated HPIV2 vaccine strain, containing both temperature sensitive (ts) and non-ts attenuating mutations, was restricted >30-fold compared to rHPIV2-WT in HAE at 32 °C and exhibited little productive replication at 37 °C. This restriction paralleled attenuation in the upper and lower respiratory tract of African green monkeys, supporting the HAE model as an appropriate and convenient system for characterizing HPIV2 vaccine candidates. Elsevier Ltd. Published by Elsevier Ltd. 2010-03-24 2010-02-05 /pmc/articles/PMC2844349/ /pubmed/20139039 http://dx.doi.org/10.1016/j.vaccine.2010.01.050 Text en Copyright © 2010 Elsevier Ltd. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Schaap-Nutt, Anne Scull, Margaret A. Schmidt, Alexander C. Murphy, Brian R. Pickles, Raymond J. Growth restriction of an experimental live attenuated human parainfluenza virus type 2 vaccine in human ciliated airway epithelium in vitro parallels attenuation in African green monkeys |
title | Growth restriction of an experimental live attenuated human parainfluenza virus type 2 vaccine in human ciliated airway epithelium in vitro parallels attenuation in African green monkeys |
title_full | Growth restriction of an experimental live attenuated human parainfluenza virus type 2 vaccine in human ciliated airway epithelium in vitro parallels attenuation in African green monkeys |
title_fullStr | Growth restriction of an experimental live attenuated human parainfluenza virus type 2 vaccine in human ciliated airway epithelium in vitro parallels attenuation in African green monkeys |
title_full_unstemmed | Growth restriction of an experimental live attenuated human parainfluenza virus type 2 vaccine in human ciliated airway epithelium in vitro parallels attenuation in African green monkeys |
title_short | Growth restriction of an experimental live attenuated human parainfluenza virus type 2 vaccine in human ciliated airway epithelium in vitro parallels attenuation in African green monkeys |
title_sort | growth restriction of an experimental live attenuated human parainfluenza virus type 2 vaccine in human ciliated airway epithelium in vitro parallels attenuation in african green monkeys |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2844349/ https://www.ncbi.nlm.nih.gov/pubmed/20139039 http://dx.doi.org/10.1016/j.vaccine.2010.01.050 |
work_keys_str_mv | AT schaapnuttanne growthrestrictionofanexperimentalliveattenuatedhumanparainfluenzavirustype2vaccineinhumanciliatedairwayepitheliuminvitroparallelsattenuationinafricangreenmonkeys AT scullmargareta growthrestrictionofanexperimentalliveattenuatedhumanparainfluenzavirustype2vaccineinhumanciliatedairwayepitheliuminvitroparallelsattenuationinafricangreenmonkeys AT schmidtalexanderc growthrestrictionofanexperimentalliveattenuatedhumanparainfluenzavirustype2vaccineinhumanciliatedairwayepitheliuminvitroparallelsattenuationinafricangreenmonkeys AT murphybrianr growthrestrictionofanexperimentalliveattenuatedhumanparainfluenzavirustype2vaccineinhumanciliatedairwayepitheliuminvitroparallelsattenuationinafricangreenmonkeys AT picklesraymondj growthrestrictionofanexperimentalliveattenuatedhumanparainfluenzavirustype2vaccineinhumanciliatedairwayepitheliuminvitroparallelsattenuationinafricangreenmonkeys |